Xiaotong Sha
State Key Laboratory Of Ophthalmology, Guangdong Provincial Key Laboratory Of Ophthalmology And Visual Science, No.54 Xianlie Road, Yuexiu District
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Plasma-derived exosomes from Graves' orbitopathy: Pathogenic entities causing tissue lesions.
Journal: Experimental eye research
Published: February 26, 2026
Canonical and Truncated Transglutaminase-2 Drive TGF-β1 Autocrine Loop to Induce Fibrosis in Graves' Orbitopathy.
Journal: Investigative ophthalmology & visual science
Published: May 13, 2025
GSDMD mediated pyroptosis induced inflammation of Graves' orbitopathy via the NF-κB/ AIM2/ Caspase-1 pathway.
Journal: Experimental eye research
Published: September 14, 2023
Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway.
Journal: International journal of molecular sciences
Published: March 02, 2023
Differential Circular RNA Expression Profiling of Orbital Connective Tissue From Patients With Type I and Type II Thyroid-Associated Ophthalmopathy.
Journal: Investigative ophthalmology & visual science
Published: November 21, 2022
Metformin Attenuates Inflammation and Fibrosis in Thyroid-Associated Ophthalmopathy.
Journal: International journal of molecular sciences
Published: October 21, 2022
Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.
Journal: International journal of molecular sciences
Published: April 06, 2022
Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
Journal: Frontiers in endocrinology
Published: March 08, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026